Global Nanomedicine Market Report 2024

Nanomedicine Global Market Report 2024 – By Type (Nanoparticles, Nanoshells, Nanotubes, Nanodevices, Other Types), By Modality (Diagnostics, Treatments), By Application (Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

Nanomedicine Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 200 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Nanomedicine Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN

Nanomedicine Market Definition

Nanomedicine refers to the use of nanotechnology in medicine. It is described as substances with a size between 1 and 100 nanometers that, in the end, should be able to precisely target tumor cells or important immune cells. Nanomedicine is an important instrument that enables personalized, targeted, and regenerative medicine by delivering improved new drugs, treatments, and implantable devices to clinicians and patients.

The main types of nanomedicine are nanoparticles, nanoshells, nanotubes, nanodevices, and others. Nanoparticles are a type of ultrafine particles usually between 1 and 100 nanometers in diameter used in making medicine and drugs. The different forms of modality include diagnostics, treatments and are used in clinical oncology, infectious diseases, clinical cardiology, orthopedics, others.

Nanomedicine Market Segmentation

The nanomedicine market covered in this report is segmented –

1) By Type: Nanoparticles, Nanoshells, Nanotubes, Nanodevices, Other Types

2) By Modality: Diagnostics, Treatments

3) By Application: Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, Other Applications

Global Nanomedicine Market Size 2023 to 2028: Graph

Nanomedicine Market Size 2024 And Growth Rate

The nanomedicine market size has grown rapidly in recent years. It will grow from $292.72 billion in 2023 to $335.25 billion in 2024 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to increased understanding of molecular biology, growing incidence of chronic diseases, demand for targeted drug delivery systems, expansion of nanoparticle imaging technologies, growing aging popuation.

Nanomedicine Market Growth Forecast

The nanomedicine market size is expected to see rapid growth in the next few years. It will grow to $594.63 billion in 2028 at a compound annual growth rate (CAGR) of 15.4%. The growth in the forecast period can be attributed to continued growth in nanotechnology research, rising investments in nanomedicine r&d, increasing focus on personalized medicine, expanding applications of nanomedicine in cancer treatment, integration of nanomedicine in infectious disease therapeutics. Major trends in the forecast period include development of multifunctional nanoparticles for therapeutics and imaging, emphasis on nanoparticle-based diagnostics and imaging agents, application of nanomedicine in regenerative medicine, growing use of nanomedicine in targeted therapy for neurological disorders, collaboration and partnerships in nanomedicine research and commercialization.

Nanomedicine Market Driver: Nanomedicine Market Growth Fueled By Rising Burden Of Chronic Diseases

The rising burden of complex and chronic diseases across the globe is expected to contribute to the growth of the nanomedicine market in the forecast period. Nanomedicine is increasingly being used in treating chronic diseases including cardiovascular disorders, diabetes, cancer, dementia, and others where it helps in the fast metabolism of drugs in the body. According to the international federation of Alzheimer's Associations, Alzheimer's Disease International, more than 50 million people are suffering from dementia globally, and is projected to double every 20 years, which will reach 80 million by 2030 and 152 million by 2050. The total cancer burden in the world is predicted to rise to 28.4 million new cancer cases in 2040. This increasing burden of chronic diseases is expected to propel the demand for effective therapeutics treatment based on nanomedicine, thus driving the growth of the nanomedicine market.

Nanomedicine Market Driver: Rising Demand For Personalized Medicine Driving Growth Of The Nanomedicine Market

The increasing demand for personalized medicine is expected to propel the growth of the nanomedicine market going forward. Personalized medicine refers to an innovative approach to medical treatment and healthcare that tailors medical decisions, practices, interventions, and drug therapies to the individual patient. Personalized medicine holds the promise of improving patient outcomes, increasing treatment efficacy, and advancing the field of healthcare through cutting-edge technology and individualized care. For instance, in October 2022, according to reports published by STAT, a US-based health-oriented news company, there were more than 75,000 genetic testing products and 300 personalized medicines. Therefore, the increasing demand for personalized medicine is driving the growth of the nanomedicine market.

Global Nanomedicine Market Major Players

Major companies operating in the nanomedicine market report are Pfizer Inc., Ablynx NV, Amgen Inc., Arrowhead Research Inc., Bio-Gate AG, Celgene Corporation, F. Hoffmann-La Roche AG, GE Healthcare, Gilead Sciences Inc., Merck AG, Nanospectra Biosciences, Nanotherapeutics Inc., NanoViricides Inc, Novartis AG, Sanofi S. A., Abraxis Bioscience Inc., Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., AuraSense Therapeutics LLC, BIND Therapeutics Inc., Camurus AB, Cerulean Pharma Inc., CytImmune Sciences, Fujifilm Holdings, Nanobiosym Inc., Nanobiotix SA, Nanogen Inc., Nanomix Crop., Nanoparticle BioChem Inc., Nanospective Inc., Nanosphere Health Sciences Inc., Nanosys Inc., PerkinElmer Inc., Selecta Biosciences Inc., Sigma-Aldrich Co. LLC

Global Nanomedicine Market Trend: Increasing Focus On Product Innovations To Provide Reliable Services To Their Customers

Major companies operating in the nanomedicine market are focusing on innovative products such as dynapro zetastar to drive revenues in their market. The novel instrument allows for simultaneous measurements of dynamic and static light scattering as well as dynamic and electrophoretic light scattering (DLS/SLS/ELS). For instance, in September 2023, Waters Corporation, a US-based company that specializes in analytical laboratory instruments and equipment launched dynapro zetastar for nanoparticle analysis. The zetastar instrument helps with the accurate development of complex biologics by combining multiple light scattering techniques, performing adaptive data capture, automatically assessing data quality, and increasing sensitivity and speed of measurements while utilizing incredibly small sample volumes. The zetastar instrument's unique flow cell design makes it possible to connect it with an autosampler, which greatly increases laboratory productivity and efficiency by enabling dozens of unattended measurements that can be carried out for several hours or even overnight.

Global Nanomedicine Market Trend: Increasing Focus On Technological Innovations To Provide Reliable Services To Their Customers

Major companies operating in the nanomedicine market are focusing on innovative technologies such as optical technology to drive revenues in their market. The goal of new optical technology is to improve and accelerate the creation of gene treatments and viral vectors. For instance, in September 2023, Corning Incorporated, a US-based technology company launched corning videodrop. Corning videodrop is an optical technique that measures the size and concentration of nanoparticles by using the concepts of interferometric microscopy. Videodrop is dependable, quick, and simple to use. Additionally, sample preparation is simple because it is label-free, and its user-friendly software interface makes operation run smoothly. Viral vectors including lentivirus, retrovirus, adenovirus, and extracellular vesicles (EVs) with a diameter of 80–500 nanometers can be physically titrated using this approach. Without labeling, the processing method uses the detection and tracking of nanoparticles to quantify the concentration and size distribution of a sample once it has been loaded. Throughout the purifying process, Videodrop can be utilized as an in-process control.

Nanomedicine Market Merger And Acquisition: Sanofi's Strategic Acquisition Of Translate Bio Is Boosting Vaccine Programs And Mrna Expertise

In August 2021, Sanofi S.A., a France-based pharmaceutical and healthcare company, acquired Translate Bio, Inc., for $3.2 billion. Under this acquisition, Sanofi accelerates the creation of currently approved Sanofi vaccination programs and opens up the possibility of investigating additional therapeutic fields. The mRNA Center of Excellence at Sanofi is being established more quickly. Full integration strengthens US talent in a promising new technology and improves drug formulation capabilities. Exploring the potential of this technology to create both best-in-class vaccines and treatments is further advanced by Translate Bio's addition of an mRNA technology platform and strong skills to our research. Translate Bio, Inc., is a US-based clinical stage biopharmaceutical company developing a new class of potentially game-changing drugs to treat conditions brought on by protein or gene malfunction or to stop infectious diseases by boosting immune defences.

Regional Outlook For The Global Nanomedicine Market

North America was the largest region in the nanomedicine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanomedicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the nanomedicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The nanomedicine market consists of sales of gold, silica, iron oxide, polymeric, liposomes, and micelles. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified)).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The nanomedicine market research report is one of a series of new reports from The Business Research Company that provides nanomedicine market statistics, including nanomedicine industry global market size, regional shares, competitors with a nanomedicine market share, detailed nanomedicine market segments, market trends and opportunities, and any further data you may need to thrive in the nanomedicine industry. This nanomedicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Nanomedicine Market Report Forecast And Analysis
Report AttributeDetails
Market Size Value In 2024 $335.25 billion
Revenue Forecast In 2033 $594.63 billion
Growth Rate CAGR of 15.4% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: Nanoparticles, Nanoshells, Nanotubes, Nanodevices, Other Types
2) By Modality: Diagnostics, Treatments
3) By Application: Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, Other Applications
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc.; Ablynx NV; Amgen Inc.; Arrowhead Research Inc.; Bio-Gate AG; Celgene Corporation; F. Hoffmann-La Roche AG; GE Healthcare; Gilead Sciences Inc.; Merck AG; Nanospectra Biosciences; Nanotherapeutics Inc.; NanoViricides Inc; Novartis AG; Sanofi S. A.; Abraxis Bioscience Inc.; Alnylam Pharmaceuticals Inc.; Arrowhead Pharmaceuticals Inc.; AuraSense Therapeutics LLC; BIND Therapeutics Inc.; Camurus AB; Cerulean Pharma Inc.; CytImmune Sciences; Fujifilm Holdings; Nanobiosym Inc.; Nanobiotix SA; Nanogen Inc.; Nanomix Crop.; Nanoparticle BioChem Inc.; Nanospective Inc.; Nanosphere Health Sciences Inc.; Nanosys Inc.; PerkinElmer Inc.; Selecta Biosciences Inc.; Sigma-Aldrich Co. LLC
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Nanomedicine Market Characteristics

    3. Nanomedicine Market Trends And Strategies

    4. Nanomedicine Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Nanomedicine Market Size and Growth

    5.1. Global Nanomedicine Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Nanomedicine Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Nanomedicine Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Nanomedicine Market Segmentation

    6.1. Global Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Nanoparticles

    Nanoshells

    Nanotubes

    Nanodevices

    Other Types

    6.2. Global Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Diagnostics

    Treatments

    6.3. Global Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Clinical Oncology

    Infectious Diseases

    Clinical Cardiology

    Orthopedics

    Other Applications

    7. Nanomedicine Market Regional And Country Analysis

    7.1. Global Nanomedicine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Nanomedicine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Nanomedicine Market

    8.1. Asia-Pacific Nanomedicine Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Nanomedicine Market

    9.1. China Nanomedicine Market Overview

    9.2. China Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Nanomedicine Market

    10.1. India Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Nanomedicine Market

    11.1. Japan Nanomedicine Market Overview

    11.2. Japan Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Nanomedicine Market

    12.1. Australia Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Nanomedicine Market

    13.1. Indonesia Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Nanomedicine Market

    14.1. South Korea Nanomedicine Market Overview

    14.2. South Korea Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Nanomedicine Market

    15.1. Western Europe Nanomedicine Market Overview

    15.2. Western Europe Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Nanomedicine Market

    16.1. UK Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Nanomedicine Market

    17.1. Germany Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Nanomedicine Market

    18.5. France Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Nanomedicine Market

    19.9. Italy Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Nanomedicine Market

    20.13. Spain Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Nanomedicine Market

    21.1. Eastern Europe Nanomedicine Market Overview

    21.2. Eastern Europe Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Nanomedicine Market

    22.1. Russia Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Nanomedicine Market

    23.1. North America Nanomedicine Market Overview

    23.2. North America Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Nanomedicine Market

    24.1. USA Nanomedicine Market Overview

    24.2. USA Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Nanomedicine Market

    25.1. Canada Nanomedicine Market Overview

    25.2. Canada Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Nanomedicine Market

    26.1. South America Nanomedicine Market Overview

    26.2. South America Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Nanomedicine Market

    27.1. Brazil Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Nanomedicine Market

    28.1. Middle East Nanomedicine Market Overview

    28.2. Middle East Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Nanomedicine Market

    29.1. Africa Nanomedicine Market Overview

    29.2. Africa Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Nanomedicine Market Competitive Landscape And Company Profiles

    30.1. Nanomedicine Market Competitive Landscape

    30.2. Nanomedicine Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Ablynx NV

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Amgen Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Arrowhead Research Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Bio-Gate AG

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Nanomedicine Market Competitive Benchmarking

    32. Global Nanomedicine Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Nanomedicine Market

    34. Nanomedicine Market Future Outlook and Potential Analysis

    34.1 Nanomedicine Market In 2028 - Countries Offering Most New Opportunities

    34.2 Nanomedicine Market In 2028 - Segments Offering Most New Opportunities

    34.3 Nanomedicine Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Nanomedicine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Nanomedicine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Pfizer Inc. Financial Performance
  • Table 75: Ablynx NV Financial Performance
  • Table 76: Amgen Inc. Financial Performance
  • Table 77: Arrowhead Research Inc. Financial Performance
  • Table 78: Bio-Gate AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Nanomedicine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Nanomedicine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Pfizer Inc. Financial Performance
  • Figure 75: Ablynx NV Financial Performance
  • Figure 76: Amgen Inc. Financial Performance
  • Figure 77: Arrowhead Research Inc. Financial Performance
  • Figure 78: Bio-Gate AG Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the nanomedicine market?

Nanomedicine refers to the use of nanotechnology in medicine. It is described as substances with a size between 1 and 100 nanometers that, in the end, should be able to precisely target tumor cells or important immune cells. Nanomedicine is an important instrument that enables personalized, targeted, and regenerative medicine by delivering improved new drugs, treatments, and implantable devices to clinicians and patients. For further insights on the nanosilica market, request a sample here

How will the nanomedicine market drivers and restraints affect the nanomedicine market dynamics? What forces will shape the nanomedicine industry going forward?

The nanomedicine market major growth driver - nanomedicine market growth fueled by rising burden of chronic diseases. For further insights on the nanosilica market, request a sample here

What is the forecast market size or the forecast market value of the nanomedicine market ?

The nanomedicine market size has grown rapidly in recent years. It will grow from $292.72 billion in 2023 to $335.25 billion in 2024 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to increased understanding of molecular biology, growing incidence of chronic diseases, demand for targeted drug delivery systems, expansion of nanoparticle imaging technologies, growing aging popuation. The nanomedicine market size is expected to see rapid growth in the next few years. It will grow to $594.63 billion in 2028 at a compound annual growth rate (CAGR) of 15.4%. The growth in the forecast period can be attributed to continued growth in nanotechnology research, rising investments in nanomedicine r&d, increasing focus on personalized medicine, expanding applications of nanomedicine in cancer treatment, integration of nanomedicine in infectious disease therapeutics. Major trends in the forecast period include development of multifunctional nanoparticles for therapeutics and imaging, emphasis on nanoparticle-based diagnostics and imaging agents, application of nanomedicine in regenerative medicine, growing use of nanomedicine in targeted therapy for neurological disorders, collaboration and partnerships in nanomedicine research and commercialization. For further insights on the nanosilica market, request a sample here

How is the nanomedicine market segmented?

The nanomedicine market is segmentedThe nanomedicine market covered in this report is segmented –
1) By Type: Nanoparticles, Nanoshells, Nanotubes, Nanodevices, Other Types
2) By Modality: Diagnostics, Treatments
3) By Application: Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, Other ApplicationsFor further insights on the nanosilica market,
request a sample here

Which region has the largest share of the nanomedicine market? What are the other regions covered in the report?

North America was the largest region in the nanomedicine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanomedicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the nanosilica market, request a sample here.

Who are the major players in the nanomedicine market?

Major companies operating in the nanomedicine market report are Pfizer Inc., Ablynx NV, Amgen Inc., Arrowhead Research Inc., Bio-Gate AG, Celgene Corporation, F. Hoffmann-La Roche AG, GE Healthcare, Gilead Sciences Inc., Merck AG, Nanospectra Biosciences, Nanotherapeutics Inc., NanoViricides Inc, Novartis AG, Sanofi S. A., Abraxis Bioscience Inc., Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., AuraSense Therapeutics LLC, BIND Therapeutics Inc., Camurus AB, Cerulean Pharma Inc., CytImmune Sciences, Fujifilm Holdings, Nanobiosym Inc., Nanobiotix SA, Nanogen Inc., Nanomix Crop., Nanoparticle BioChem Inc., Nanospective Inc., Nanosphere Health Sciences Inc., Nanosys Inc., PerkinElmer Inc., Selecta Biosciences Inc., Sigma-Aldrich Co. LLC For further insights on the nanosilica market, request a sample here.

What are the key trends in the nanomedicine market?

Major trend in the nanomedicine market - increasing focus on product innovations to provide reliable services to their customers. For further insights on the nanosilica market, request a sample here.

What are the major opportunities in the nanomedicine market? What are the strategies for the nanomedicine market?

For detailed insights on the major opportunities and strategies in the nanomedicine market, request a sample here.

How does the nanomedicine market relate to the overall economy and other similar markets?

For detailed insights on nanomedicine market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the nanomedicine industry?

For detailed insights on the mergers and acquisitions in the nanomedicine industry, request a sample here.

What are the key dynamics influencing the nanomedicine market growth? SWOT analysis of the nanomedicine market.

For detailed insights on the key dynamics influencing the nanomedicine market growth and SWOT analysis of the nanomedicine industry, request a sample here.